Company: XAIR
Filing Date: 2025-06-20
Form Type: 10-K
Source: 0001641172-25-015750
Chunk: 944

Company: Beyond Air, Inc.
Filing Date: 2025-06-20
Form: 10-K
Item: Item 1A
Chunk 944
---
IDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 14 VARIABLE INTEREST
ENTITIES (continued)

The following table summarizes segment financial information
by business segment for the year ended and at March 31, 2024:

 SCHEDULE
OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT

    (in thousands) 
    Beyond Air  
    Beyond Cancer  
     NeuroNos  
    Total 
  
    Cash, cash equivalents and marketable securities 
    $23,591  
    $10,877  
    $      -  
    $34,468 
  
    All other assets 
     21,747  
     746  
     -  
     22,493 
  
    Total assets 
    $45,338  
    $11,623  
    $-  
    $56,961 
  
    Total liabilities 
     (28,810) 
     (965) 
     -  
     (29,775)
  
    Net assets 
    $16,528  
    $10,658  
    $-  
    $27,186 
  
    Non-controlling interest 
    $-  
    $2,138  
    $-  
    $2,138 
  
    Capital expenditures 
    $5,502  
    $243  
    $-  
    $5,745 

    Revenues 
    $1,159  
    $-  
    $-  
    $1,159 
  
    Cost of revenues 
     (2,466) 
     -  
     -  
     (2,466)
  
    Research and development 
     (15,527) 
     (8,836) 
     -  
     (24,363)
  
    Selling, general, and administrative 
     (25,271) 
     (12,066) 
     -  
     (37,337)
  
    Loss from operations 
     (42,105) 
     (20,902) 
     -  
     (63,006)
  
    Interest and finance expense 
     (2,912) 
     -  
     -  
     (2,912)
  
    Other non